aspirin-in-hand-xandert-morguefileA new study may have found a specific patient population that may live longer by taking this drug: Colon cancer patients.

After reviewing data from 964 colorectal cancer patients, researchers at the Dana-Farber Cancer Institute in Boston found when patients whose tumors had a mutated form of the PIK3CA gene took aspirin after being diagnosed, they lived significantly longer than patients without the mutation.

(READ the article from CNN)

Thanks to Joel Arellano for submitting the link on our Facebook Page!

Leave a Reply